TrialAnnals of surgical oncology2026

Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial.

Changhoon Yoo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.